Pathogenesis of pre-eclampsia: Marinobufagenin and angiogenic imbalance as biomarkers of the syndrome

Translational Research

Volumn 160, Issue 2, 2012, Pages 99-113

  Uddin, Mohammad N ^a   Allen, Steven R ^a   Jones, Richard O ^a   Zawieja, David C ^b   Kuehl, Thomas J ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BETA CATENIN; BIOLOGICAL MARKER; BUFOGENIN; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CLAUDIN 1; ENDOGLIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERLEUKIN 6; MARINOBUFAGENIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OCCLUDIN; PLACENTAL GROWTH FACTOR; PROTEIN SLC4A1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM PROTON EXCHANGE PROTEIN 3; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL REACTIVITY; CYTOTROPHOBLAST; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GESTATIONAL AGE; HUMAN; HYPERTENSION; IN VITRO STUDY; MONOLAYER CULTURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PERMEABILITY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPTOM; TIGHT JUNCTION; URINARY EXCRETION;

EID: 84863922700     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.01.005     Document Type: Review

References (132)

1. G. Pridjian, and J.B. Puschett Pre-eclampsia, part I: clinical and pathophysiological considerations Obstet Gynecol Surv 57 2002 598 618 (Pubitemid 34977665)
2. G. Pridjian, and J.B. Puschett Pre-eclampsia, part II: experimental and genetic considerations Obstet Gynecol Surv 57 2002 619 640 (Pubitemid 34977666)
3. C.J. Berg, H.K. Atrash, L.M. Koonin, and M. Tucker Pregnancy-related mortality in the United States, 1987-1990 Obstet Gynecol 88 1996 161 167 (Pubitemid 26250284)
4. World Health Organization Maternal mortality in 2000; Estimates Developed by WHO, UNICEF and UNFPA 2004 World Health Organization Geneva
5. J.M. Roberts, and C.W. Redman Pre-eclampsia: more than pregnancy-induced hypertension Lancet 341 1993 1447 1451 (Pubitemid 23161452)
6. G.G. Zeeman Neurologic complications of pre-eclampsia Semin Perinatol 33 2009 166 172
7. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, and M.K. McLaughlin Pre-eclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 1989 1200 1204
8. J.B. Puschett The role of excessive volume expansion in the pathogenesis of pre-eclampsia Med Hypotheses 67 2006 1125 1132 (Pubitemid 44302258)
9. L.C. Chesley Plasma and red cell volumes during pregnancy Am J Obstet Gynecol 112 1972 440 450
10. E.D.M. Gallery, S.N. Hunyor, and A.Z. Györy Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy Q J Med 48 1979 593 602 (Pubitemid 10210779)
11. P.M. Hays, D.P. Cruikshank, and L.J. Dunn Plasma volume determination in normal and pre-eclamptic pregnancies Obstet Gynecol 151 1985 958 966 (Pubitemid 15237734)
12. M.A. Brown, V.C. Zammit, and D.M. Mitar Extracellular fluid volumes in pregnancy-induced hypertension J Hypertens 10 1992 61 68
13. D.M. Campbell, A.J. Campbell, and R. Gordons Evans blue disappearance rate in normal and pre-eclamptic pregnancy Clin Exp Hypertens 2 1983 163 169 (Pubitemid 14148045)
14. M. Ianosi-Irimie, H.V. Vu, and J.M. Whitbred A rat model of pre-eclampsia Clin Exp Hypertens 8 2005 605 617
15. E. Agunanne, D. Horvat, M.N. Uddin, and J. Puschette The treatment of pre-eclampsia in a rat model employing Digibind® Am J Perinatol 27 2010 299 305
16. M.N. Uddin, L.B. McLean, and F.A. Hunter Vascular leak in a rat model of pre-eclampsia Am J Nephrol 30 2009 26 33
17. M.N. Uddin, D. Horvat, E.W. Childs, and J.B. Puschett Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling Am J Physiol Regul Integr Comp Physiol 296 2009 R1726 R1734
18. M.N. Uddin, D. Horvat, and S.S. Glaser Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells Placenta 29 2008 266 273
19. M.N. Uddin, D. Horvat, S.S. Glaser, B.M. Mitchell, and J.B. Puschett Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function J Biol Chem 283 2008 17946 17953
20. H. Vu, M. Ianosi-Irimie, and S. Danchuk Resibufogenin corrects hypertension in a rat model of human pre-eclampsia Exp Biol Med 231 2006 215 220 (Pubitemid 43213459)
21. H. Vu, M. Ianosi Irimie, and C.A. Pridjian Involvement of marinobufagenin in a rat model of human pre-eclampsia Am J Nephrol 25 2005 520 528 (Pubitemid 41433898)
22. D. Horvat, J. Severson, M.N. Uddin, B. Mitchell, and J.B. Puschett Resibufogenin prevents the manifestations of pre-eclampsia in an animal model of the syndrome Hypertens Pregnancy 27 2010 513 711
23. M.N. Uddin, E. Agunanne, D. Horvat, and J.B. Puschett Alterations in the renin-angiotensin system in a rat model of human pre-eclampsia Am J Nephrol 31 2010 171 177
24. M.N. Uddin, E.E. Agunanne, D. Horvat, and J.B. Puschett Resibufogenin administration prevents oxidative stress in a rat model of human pre-eclampsia Hypertens Pregnancy 31 2012 70 78
25. M.N. Uddin, D. Horvat, S. Demorrow, E.E. Agunanne, and J.B. Puschett Marinobufagenin is an upstream modulator of Gadd45a stress signaling in pre-eclampsia Biochim Biophys Acta 1812 2011 49 58
26. O.V. Fedorova, A.S. Simbirtsev, and N.I. Kolodkin Monoclonal antibody to an endogenous bufodienolide, marinobufagenin, reverses pre-eclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension J Hypertens 26 2008 2414 2425
27. C.D. Adair, V. Buckalew, and K. Taylor Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin Am J Nephrol 16 1996 529 531 (Pubitemid 26387940)
28. S.J. Kittner, B.J. Stern, and B.R. Feeser Pregnancy and the risk of stroke N Engl J Med 335 1996 768 774 (Pubitemid 26296536)
29. T. Sharshar, C. Lamy, and J.L. Mas For the Stroke in Pregnancy Study Group, Incidence and causes of strokes associated with pregnancy and puerperium Stroke 26 1995 930 936
30. T. Ito, T. Sakai, S. Inagawa, M. Utsu, and T. Bun MR angiography of cerebral vasospasm in pre-eclampsia Am J Neuroradiol 16 1995 1344 1346
31. O.B. Paulson Blood-brain barrier, brain metabolism and cerebral blood flow Eur Neuropsychopharmacol 12 2002 495 501 (Pubitemid 35408700)
32. R.B. Schwartz, S.K. Feske, and J.F. Polak Pre-eclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy Radiology 217 2000 371 376
33. J.B. Puschett, E. Agunanne, and M.N. Uddin Emerging role of the bufodienolides in cardiovascular and renal disease Am J Kidney Dis 56 2010 359 370
34. D.E. Scott Anemia in pregnancy Obstet Gynecol Annu 1 1972 219 244
35. J.T. Repke, and J.N. Robinson The prevention and management of pre-eclampsia and eclampsia Int J Gynaecol Obstet 62 1998 1 9 (Pubitemid 28342629)
36. M.G. Mohaupt [Edema in pregnancy-trivial?] Other Umsch 61 2004 687 690
37. L.C. Chesley The renal excretion of sodium in women with pre-eclampsia Clin Obstet Gynecol 1 1958 317 323
38. L.C. Chesley, C. Valenti, and H. Rein Excretion of sodium loads by nonpregnant and pregnant normal, hypertensive and pre-eclamptic women Metabolism 7 1958 575 588
39. E.D. Freis, and J.F. Kenny Plasma volume, total circulating protein, and "available fluid" abnormalities in pre-eclampsia and eclampsia J Clin Invest 27 1948 283 289
40. D.E. Scott, and J.A. Pritchard Iron deficiency in healthy young college women JAMA 199 1967 147 150
41. R. Hayman, J. Brockelsby, L. Kenny, and P. Baker Pre-eclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor J Soc Gynecol Investig 6 1999 3 10 (Pubitemid 29093399)
42. M.A. Brown, E.D.M. Gallery, M.R. Ross, and R.P. Esber Sodium excretion in normal and hypertensive pregnancy: a prospective study Am J Obstet Gynecol 159 1988 297 307
43. J.B. Puschett Enoch Agunanne, Uddin MN. Marinobufagenin, resibufagenin, and pre-eclampsia Biochim Biophys Acta 1802 2010 1246 1253
44. S.E. Maynard, J. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1(sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
45. G. Wallukat, V. Homuth, and T. Fischer Nine patients with pre-eclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor J Clin Invest 103 1999 945 952 (Pubitemid 29169601)
46. F.G. Cunningham Hypertensive disorders in pregnancy F.G. Cunningham, J.C. Hauth, K.J. Leveno, Williams obstetrics 22nd ed. 2005 McGraw-Hill New York 761 808
47. C.R. Parker Jr., R.B. Everett, P.J. Whalley, J.G. Quirk Jr., N.F. Gant, and P.C. MacDonald Hormone production during pregnancy in the primigravid patient. II. Plasma levels of deoxycorticosterone throughout pregnancy of normal women and women who developed pregnancy-induced hypertension Am J Obstet Gynecol 138 1980 626 631 (Pubitemid 11250601)
48. A.C. Morrison, S.K. Srinivas, M.A. Elovitz, and J.B. Puschett Genetic variation in solute carrier genes is associated with pre-eclampsia Am J Obstet Gynecol 203 2010 491.e1 491.e13
49. M.L. Tjoa, R.J. Levine, and S.A. Karumanchi Angiogenic factors in pre-eclampsia Front Biosci 12 2007 2395 2402
50. B. Lamarca, J. Brewer, and K. Wallace IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Infereron Cytokine Mediator Res 2011 2011 59 64
51. C.W. Redman, G.P. Sacks, and I.L. Sargent Pre-eclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 180 1999 499 506 (Pubitemid 29093892)
52. I.A. Greer, J. Dawes, T.A. Johnston, and A.A. Calder Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension Obstet Gynecol 78 1991 28 32
53. W. Ramma, and A. Ahmed Is inflammation the cause of pre-eclampsia? Biochem Soc Trans 39 2011 1619 1627
54. B.D. LaMarca, M.J. Ryan, J.S. Gilbert, S.R. Murphy, and J.P. Granger Inflammatory cytokines in the pathophysiology of hypertension during pre-eclampsia Curr Hypertens Rep 9 2007 480 485
55. W. Schoner Endogenous cardiac glycosides, a new class of steroid hormones Eur J Biochem 269 2002 2440 2448 (Pubitemid 34539271)
56. W. Schoner, and G. Scheiner-Bobis Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer Semin Nephrol 25 2005 343 351 (Pubitemid 41749417)
57. W. Schoner, and G. Scheiner-Bobis 7 Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol 293 2007 509 536
58. S. Bova, M.P. Blaustein, J. Ludens, D. Harris, D. DuCharme, and J.M. Hamlyn Effect of an endogenous ouabain like compound on heart and aorta Hypertension 17 1991 944 950
59. H. Ooi, and W. Colucci Pharmacological treatment of heart failure J.E. Hardman, L.E. Limbird, A.G. Gilman, Goodman and Gilman's pharmacological basis of therapeutics 10th ed. 2001 McGraw-Hill New York 901 932
60. A.Y. Bagrov, J.I. Shapiro, and O.V. Fedorova Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets Pharmacol Rev 61 2009 9 38
61. D.A. Lopatin, E.K. Ailamazian, and R.I. Dmitrieva Circulating bufodienolide and cardenolide sodium pump inhibitors in pre-eclampsia J Hypertens 17 1999 1179 1187 (Pubitemid 29389566)
62. A.Y. Bagrov, and O.V. Fedorova Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries J Hypertens 16 1998 1953 1958 (Pubitemid 29002373)
63. O.V. Fedorova, N.I. Kolodkin, N.I. Agalakova, E.G. Lakatta, and A.Y. Bagrov Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats Hypertension 37 2001 462 466 (Pubitemid 32199012)
64. H.C. Gonick, Y. Ding, N.D. Vaziri, A.Y. Bagrov, and O.V. Fedorova Simultaneous measurement of marinobufagenin, ouabain, and hypertension- associated protein in various disease states Clin Exper Hypertens 20 1998 617 627 (Pubitemid 28319534)
65. I.V. Averina, N.I. Tapilskaya, V.A. Reznik, E.V. Frolova, E.G. Lakatta, and A.Y. Bagrov Endogenous Na/K-ATPase inhibitors in patients with pre-eclampsia Cell Mol Biol 52 2006 19 23 (Pubitemid 46799700)
66. H.E. de Wardener The concept of the neutriuretic hormone and its relation to hypertension Clin Exp Hypertens 7 1985 647 662 (Pubitemid 15071785)
67. M.P. Blaustein Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis Am J Physiol 232 1977 C165 C173
68. A.Y. Bagrov, O.V. Fedorova, R.I. Dmitrieva, A.W. French, and D.E. Anderson Plasma- marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs Cardiovasc Res 31 1996 296 305 (Pubitemid 26090901)
69. O.V. Fedorova, P.A. Doris, and A.Y. Bagrov Endogenous marinobufagenin-like factor in acute plasma volume expansion Clin Exp Hypertens 20 1998 581 591 (Pubitemid 28319530)
70. J.M. Hamlyn, R. Ringel, and J. Schaeffer A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension Nature 300 1982 650 652 (Pubitemid 13253322)
71. M.B. Pamnani, S. Chen, C.M. Yuan, and F.J. Haddy Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats Hypertension 23 1 Suppl 1994 I106 I109
72. H.L. LaMarca, C.A. Morris, G.R. Pettit, T. Nagowa, and J.B. Puschett Marinobufagenin impairs first trimester cytotrophoblast differentiation Placenta 27 2006 984 988 (Pubitemid 44204032)
73. E.R. Nortwitz, D.J. Schust, and S.J. Fisher Implantation and the survival of early pregnancy N Eng J Med 345 2001 1400 1408
74. R. Pijnenbort, G. Dixon, W.B. Robertson, and I. Brosens Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy Placenta 1 1980 3 19 (Pubitemid 11240946)
75. A.M. Sharkey, J.C. Cooper, and J.R. Balmforth Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and pregnancies complicated by pre-eclampsia Eur J Clin Invest 26 1996 1182 1185
76. F. Lyall, I.A. Greer, F. Boswell, and R. Fleming Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and pre-eclampsia Br J Obstet Gynaecol 104 1997 223 228 (Pubitemid 27065149)
77. J.C. Livingston, R. Chin, B. Haddad, E.T. McKinney, R. Ahokas, and B.M. Sibai Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe pre-eclampsia Am J Obstet Gynecol 183 2000 1554 1557 (Pubitemid 32061224)
78. P.N. Baker, J. Krasnow, J.M. Roberts, and K.T. Yeo Elevated serum levels of vascular endothelial growth factor in patients with pre-eclampsia Obstet Gynecol 86 1995 815 821
79. J.S. Gilbert, S.A. Babcock, and J.P. Granger Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression Hypertension 50 2007 1142 1147 (Pubitemid 350172938)
80. R.J. Levine, S.E. Maynard, and C. Qian Circulating Angiogenic factors and the risk of pre-eclampsia N Engl J Med 350 2004 672 683 (Pubitemid 38364626)
81. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of pre-eclampsia Nature Med 12 2006 642 649 (Pubitemid 43865232)
82. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in pre-eclampsia N Engl J Med 355 2006 992 1006
83. C.G. Solomon, and E.W. Seely Pre-eclampsia-searching for the cause N Eng J Med 350 2004 641 642
84. N.F. Gant, G.L. Daley, S. Chand, P.J. Whalley, and P.C. MacDonald A study of angiotensin II pressor response throughout primigravid pregnancy J Clin Invest 52 1973 2682 2689
85. P.H. Baker, M.D. Kilby, and F. Broughton Pipkin The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy J Hypertens 10 1992 55 60
86. F. Broughton Pipkin The renin-angiotensin system in normal and hypertensive pregnancies P.C. Rubin, (Series) Handbook of hypertension: hypertension in pregnancy 1988 Elsevier Science Publishers B.V. New York, NY 118 151
87. M. Hanssens, M. Keirse, B. Spitz, and F.A. Van Assche Measurement of individual plasma angiotensins in normal pregnancy and pregnancy-induced hypertension J Clin Endocrinol Metab 73 1991 489 494 (Pubitemid 21921899)
88. M. Hanssens, M. Keirse, B. Spitz, and F.A. Van Assche Angiotensin II levels in hypertensive and normotensive pregnancies Br J Obstet Gynaecol 98 1991 155 161
89. H.P. Luther, V. Homuth, and G. Wallukat α 1-adrenergic receptor antibodies in patients with primary hypertension Hypertension 29 1997 678 682 (Pubitemid 27074736)
90. Y. Xia, S.M. Ramin, and R.E. Kellems Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of pre-eclampsia Hypertension 50 2007 269 275 (Pubitemid 47205769)
91. R. Dechend, V. Homuth, and G. Wallukat AT1 receptor agonistic antibodies from pre-eclamptic patients cause vascular cells to express tissue factor Circulation 101 2000 2382 2387 (Pubitemid 30329128)
92. Y. Xia, H. Wen, S. Bobst, M.C. Day, and R.E. Kellems Maternal autoantibodies from pre-eclamptic patients activate angiotensin receptors on human trophoblast cells J Soc Gynecol Investig 10 2003 82 93 (Pubitemid 36184763)
93. T.M. Thway, S.G. Shlykov, and M.C. Day Antibodies from pre-eclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation Circulation 110 2004 1612 1619 (Pubitemid 39297984)
94. C.C. Zhou, Y. Zhang, and R.A. Irani Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice Nat Med 14 2008 855 862
95. C.C. Zhou, S. Ahmad, and T. Mi Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy Circ Res 100 2007 88 95 (Pubitemid 46074969)
96. F. Herse, A.C. Staff, L. Hering, D.N. Muller, F.C. Luft, and R. Dechend AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia J Mol Med 86 2008 697 703
97. R. Dechend, C. Viedt, and D.N. Müller 3 AT1 receptor agonistic antibodies from pre-eclamptic patients stimulate NADPH oxidase Circulation 107 2003 1632 1639 (Pubitemid 36401560)
98. M.R. Parrish, K. Wallace, and K.B. Tam Tam Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension Am J Hypertens 24 2011 835 840
99. B. LaMarca, K. Wallace, and J. Granger Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in pre-eclampsia Curr Opin Pharmacol 11 2011 175 179
100. D.M. Shah Role of the renin-angiotensin system in the pathogenesis of pre-eclampsia Am J Physiol Renal Physiol 288 2005 F614 F625
101. S.L. Skinner, E.R. Lumbers, and E.M. Symonds Analysis of changes in the renin-angiotensin system during pregnancy Clin Sci 42 1972 479 488
102. M.A. Brown, V.C. Zammit, D.A. Mitar, and J.A. Whitworth Renin-aldosterone relationships in pregnancy-induced hypertension Am J Hypertens 5 1992 366 371
103. E.M. Symonds, F. Broughton Pipkin, and D.J. Craven Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy Br J Obstet Gynaecol 82 1975 643 650
104. R. Abdul-Karim, and N. Assali Pressor response to angiotonin in pregnant and nonpregnant women Am J Obstet Gynecol 82 1961 246 251
105. A.C. Cooper, G. Robinson, G.P. Vinson, W.T. Cheung, and F. Broughton Pipkin The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy Placenta 20 1999 467 474 (Pubitemid 29301620)
106. A.H. Nielsen, K.H. Schauser, and K. Poulsen The uteroplacental renin-angiotensin system Placenta 21 2000 468 477 (Pubitemid 30609350)
107. T. Morgan, C. Craven, and K. Ward Human spiral artery renin-angiotensin system Hypertension 32 1998 683 687 (Pubitemid 28480544)
108. C. Li, R. Ansari, Z. Yu, and D. Shah Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells Hypertension 36 2000 159 164 (Pubitemid 30626982)
109. A.H. Nielsen, K.H. Schauser, and K. Poulsen Current topic: the uteroplacental renin-angiotensin system Placenta 21 2000 468 477 (Pubitemid 30609350)
110. H.S. Brar, S.L. Kjos, W. Dougherty, Y.S. Do, H.B. Tam, and W.A. Hsueh Increased feto-placental active renin production in pregnancy-induced hypertension Am J Obstet Gynecol 157 1987 363 367
111. P.S. Leung, S.J. Tsai, G. Wallukat, T.N. Leung, and T.K. Lau The up-regulation of angiotensin II receptor AT1 in human pre-eclamptic placenta Mol Cell Endocrinol 184 2001 95 102 (Pubitemid 32994800)
112. M. Ito, A. Itakura, and Y. Ohno Possible activation of the renin-angiotensin system in the feto-placental unit in pre-eclampsia J Clin Endocrinol Metab 87 2002 1871 1878 (Pubitemid 34615282)
113. R.A. Irani, and Y. Xia Renin angiotensin signaling in normal pregnancy and pre-eclampsia Semin Nephrol 31 2011 47 58
114. A. Agunanne, M.N. Uddin, D. Horvat, and J.B. Puschett Contribution of angiogenic factors in a rat model of pre-eclampsia Am J Nephrol 32 2010 332 339
115. Y. Xiong, D.A. Liebermann, and J.S. Tront Gadd45a stress signaling regulates sFlt-1 expression in pre-eclampsia J Cell Physiol 220 2009 632 639
116. K.B. Tam Tam, B. Lamarca, and M. Arany Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats Am J Hypertens 24 2011 110 113
117. J.P. Bridges, J.S. Gilbert, and D. Colson Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats Am J Hypertens 22 2009 564 568
118. M. Sedeek, J.S. Gilbert, and B.B. LaMarca Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats Am J Hypertens 21 2008 1152 1156
119. K.A. Okanloma, and J. Moodley Neurological complications associated with the pre-eclampsia/ eclampsia syndrome Int J Gynecol Obstet 71 2000 223 225
120. M.J. Cipolla Cerebrovascular function in pregnancy and eclampsia Hypertension 50 2007 14 24 (Pubitemid 46986001)
121. A.G. Euser, and M.J. Cipolla Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats Hypertension 49 2007 334 340 (Pubitemid 46143010)
122. M.J. Cipolla, N. DeLance, and I. Vitullo Pregnancy prevents hypertensive remodeling of cerebral arteries Hypertension 47 2006 619 626
123. R.W. Readline, and P. Patterson Pre-eclampsia is associated with an excess of proliferative immature intermediated trophoblast Hum Pathol 26 1995 594 600
124. S.J. Fisher The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of pre-eclampsia Reprod Biol Endocrinol 2 2004 53
125. K. Red-Horse, Y. Zhou, and O. Genbacev Trophoblast differentiation during embryo implantation and formation of the maternal-fetal life interface J Clin Invest 114 2004 744 754 (Pubitemid 39578730)
126. A. Kharfi, Y. Giguere, V. Sapin, J. Masse, B. Dastugue, and J.C. Forest Trophoblastic remodeling in normal and pre-eclamptic pregnancies: implication of cytokines Clin Biochem 36 2003 323 331 (Pubitemid 36776800)
127. E. Svedas, K.B. Islam, H. Nisell, and K.R. Kublickiene Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women Am J Obstet Gynecol 188 2003 168 176 (Pubitemid 36135615)
128. E.W. Childs, B. Tharakan, F.A. Hunter, J.H. Tinsley, and X. Cao Apoptotic signaling induces hyperpermeability following hemorrhagic shock Am J Physiol Heart Circ Physiol 292 2007 H3179 H3189
129. N. Gautam, H. Herwald, P. Hedqvist, and L. Lindbom Signaling via beta (2) integrins triggers neutrophil-dependent alteration in endothelial barrier function J Exp Me 191 2000 1829 1839 (Pubitemid 30390347)
130. S. Jalali, Y.S. Li, and M. Sotoudeh Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells Arterioscler Thromb Vasc Biol 18 1998 227 234 (Pubitemid 28277599)
131. Y. Wang, Y. Gu, D.N. Granger, J.M. Roberts, and J.S. Alexander Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during pre-eclampsia Am J Obstet Gynecol 186 2002 214 220 (Pubitemid 34165436)
132. M.N. Uddin, E.E. Agunanne, D. Horvat, and J.B. Puschett Marinobufagenin causes enhanced permeability in human brain microvascular endothelial cells via apoptotic signaling J Am Soc Nephrol 20 2009 534A 535A